Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Nephrology/Urology
Clinical Trials: Glomerulonephritis
A listing of clinical trials currently looking for volunteers to enroll in Glomerulonephritis studies. Click on the closest city to find more detailed information on a research study in your area.
Alabama
Birmingham : Updated
A Study of the Safety and Efficacy of an Interleukin-6 Inhibitor in Patients With Lupus Nephritis
Connecticut
Danbury : Research Site
Safety Study of AMG 811 in Subjects With Systemic Lupus Erythematosus With and Without Glomerulonephritis
Illinois
Chicago : Updated
A Study of the Safety and Efficacy of an Interleukin-6 Inhibitor in Patients With Lupus Nephritis
Kansas
Kansas City : Research Site
Safety Study of AMG 811 in Subjects With Systemic Lupus Erythematosus With and Without Glomerulonephritis
New York
Lake Success : Updated
A Study of the Safety and Efficacy of an Interleukin-6 Inhibitor in Patients With Lupus Nephritis
Manhasset : Research Site
Safety Study of AMG 811 in Subjects With Systemic Lupus Erythematosus With and Without Glomerulonephritis
Ohio
Columbus : Updated
A Study of the Safety and Efficacy of an Interleukin-6 Inhibitor in Patients With Lupus Nephritis
Pennsylvania
Duncansville : Updated
A Study of the Safety and Efficacy of an Interleukin-6 Inhibitor in Patients With Lupus Nephritis
Duncansville : Research Site
Safety Study of AMG 811 in Subjects With Systemic Lupus Erythematosus With and Without Glomerulonephritis
Tennessee
Chattanooga : Updated
A Study of the Safety and Efficacy of an Interleukin-6 Inhibitor in Patients With Lupus Nephritis
Texas
Amarillo : Research Site
Safety Study of AMG 811 in Subjects With Systemic Lupus Erythematosus With and Without Glomerulonephritis
Carrollton : Updated
A Study of the Safety and Efficacy of an Interleukin-6 Inhibitor in Patients With Lupus Nephritis
Dallas : Research Site
Safety Study of AMG 811 in Subjects With Systemic Lupus Erythematosus With and Without Glomerulonephritis
Belgium
Brussels : Updated
A Study of the Safety and Efficacy of an Interleukin-6 Inhibitor in Patients With Lupus Nephritis
Leuven : Updated
A Study of the Safety and Efficacy of an Interleukin-6 Inhibitor in Patients With Lupus Nephritis
Roeselare : Updated
A Study of the Safety and Efficacy of an Interleukin-6 Inhibitor in Patients With Lupus Nephritis
Canada
Toronto : University Health Network- Toronto General Hospital
A Dose Escalation Study of Long-acting ACTH Gel in Membranous Nephropathy
France
Paris Cedex 13 : Research Site
Safety Study of AMG 811 in Subjects With Systemic Lupus Erythematosus With and Without Glomerulonephritis
Hong Kong
Hong Kong : Research Site
Safety Study of AMG 811 in Subjects With Systemic Lupus Erythematosus With and Without Glomerulonephritis
Korea, Republic of
Busan : Inje University Haeundae Paik Hospital
Mycophenolate Mofetil in Patients With Progressive Idiopathic Membranous Nephropathy
Busan : Dong-A University Medical Center
Mycophenolate Mofetil in Patients With Progressive Idiopathic Membranous Nephropathy
Daegu : Kyungpook National University Hospital
Mycophenolate Mofetil in Patients With Progressive Idiopathic Membranous Nephropathy
Daegu : Yeungnam University Medical Center
Mycophenolate Mofetil in Patients With Progressive Idiopathic Membranous Nephropathy
Daegu : Daegu Fatima Hospital
Mycophenolate Mofetil in Patients With Progressive Idiopathic Membranous Nephropathy
View More »
Seoul : Seoul National University Hospital
Mycophenolate Mofetil in Patients With Progressive Idiopathic Membranous Nephropathy
Seoul : Yonsei University Hospital
Mycophenolate Mofetil in Patients With Progressive Idiopathic Membranous Nephropathy
Seoul : Boramae Medical Center
Mycophenolate Mofetil in Patients With Progressive Idiopathic Membranous Nephropathy
Ulsan : Ulsan University Hospital
Mycophenolate Mofetil in Patients With Progressive Idiopathic Membranous Nephropathy
Malaysia
Kuala Lumpur : Research Site
Safety Study of AMG 811 in Subjects With Systemic Lupus Erythematosus With and Without Glomerulonephritis
Mexico
Guadalajara, Jalisco : Updated
A Study of the Safety and Efficacy of an Interleukin-6 Inhibitor in Patients With Lupus Nephritis
Mexico : Updated
A Study of the Safety and Efficacy of an Interleukin-6 Inhibitor in Patients With Lupus Nephritis
Mexico : Research Site
Safety Study of AMG 811 in Subjects With Systemic Lupus Erythematosus With and Without Glomerulonephritis
Mexico : Research Site
Safety Study of AMG 811 in Subjects With Systemic Lupus Erythematosus With and Without Glomerulonephritis
México : Updated
A Study of the Safety and Efficacy of an Interleukin-6 Inhibitor in Patients With Lupus Nephritis
Netherlands
Maastricht : Updated
A Study of the Safety and Efficacy of an Interleukin-6 Inhibitor in Patients With Lupus Nephritis
Rotterdam : Updated
A Study of the Safety and Efficacy of an Interleukin-6 Inhibitor in Patients With Lupus Nephritis
Poland
Gdansk : Updated
A Study of the Safety and Efficacy of an Interleukin-6 Inhibitor in Patients With Lupus Nephritis
Wroclaw : Updated
A Study of the Safety and Efficacy of an Interleukin-6 Inhibitor in Patients With Lupus Nephritis
Thailand
Bangkok : Updated
A Study of the Safety and Efficacy of an Interleukin-6 Inhibitor in Patients With Lupus Nephritis
Chiang Mai : Updated
A Study of the Safety and Efficacy of an Interleukin-6 Inhibitor in Patients With Lupus Nephritis
